Robert L. Murphy: Clinical Trials

1 trial sponsored by Robert L. Murphy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Robert L. Murphy: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir
DNA + HIV-rAd5 vaccine, ART intensification (raltegravir), ART intensification (maraviroc) - HIV Infection
Phase 2CompletedRobert L. Murphy282009-11-012014-09-12

Conditions studied

HIV Infections (1)

Interventions

DNA (1)  ·  Maraviroc (1)  ·  Raltegravir Potassium (1)

Countries

United States (1)

Top investigators

Robert Murphy, MD (1)

Results publications

PMID 26424549